Synaptogenix, Inc.
SNPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $16,623 | $12,287 | $3,353 | $4,281 |
| - Cash | $1,445 | $14,370 | $14,833 | $17,656 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $15,178 | -$2,083 | -$11,480 | -$13,375 |
| Revenue | $0 | $4 | $0 | $5 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $0 | $4 | -$1 | $3 |
| % Margin | – | 100% | – | 50% |
| EBITDA | -$3,922 | -$2,335 | $386 | -$2,177 |
| % Margin | – | -58,935.1% | – | -40,085.2% |
| Net Income | -$3,968 | -$17,516 | $385 | -$5,547 |
| % Margin | – | -442,101.9% | – | -102,108.4% |
| EPS Diluted | -1.56 | -11.26 | 0.12 | -4.58 |
| % Growth | 86.1% | -9,483.3% | 102.6% | – |
| Operating Cash Flow | -$1,195 | -$749 | -$2,001 | -$1,168 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,195 | -$749 | -$2,001 | -$1,168 |